Qiujun Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Qiujun Zhou has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
- Yi Cao
The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine)
4 shared publications - Maocan Tao
The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine)
3 shared publications Fei Liu
Jinhua People's Hospital Jinhua China
2 shared publicationsHui Wang
Department of First Clinical Medical College Zhejiang Chinese Medical University Hangzhou China
2 shared publications- Huifeng Yang
Department of First Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Hangzhou, China 310000
2 shared publications - Jinhui Wang
Wenzhou City Hospital of Traditional Chinese Medicine and Western Medicine Combined, Wenzhou, China
2 shared publications
Latest Publications
- Open Access
- 19 September 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (38) , e44156
Efficacy and safety of ROI-C™ self-locking system versus cage combined with screw-plate internal fixation in the treatment of degenerative cervical disease: A meta-analysis
Background: This meta-analysis rigorously compares the efficacy and safety of the ROI-C™ self-locking system with that of the traditional cage combined with screw-plate (CCP) internal fixation in treating degenerative cervical disease. The goal is to enhance surgical decision-making and improve patient outcomes in managing this condition. Methods: In this meta-analysis, we searched the PubMed, Embase, and Cochrane Library databases from their establishment to May 2024. We proposed to include randomized controlled trials (RCTs) and non-RCTs reported ROI-C™ self-locking system and CCP internal fixation for patients with degenerative cervical spondylosis, excluding published and unpublished literature on other study types, literature with incomplete or inadequate information, animal experiments, literature reviews, and systematic studies. Data were processed using STATA 15.1 software. Results: These studies encompassed both cohort studies and 1 RCT, involving a total of 918 patients (449 in the ROI-C group and 469 in the CCP group). Meta-analysis results showed that the ROI-C™ system is associated with shorter operation time and less blood loss compared to the CCP group. The incidences of postoperative adjacent segment degeneration and dysphagia were significantly lower in the ROI-C group. However, differences in Japanese Orthopedic Association scores, neck disability index scores, cervical lordosis, fusion rate, and cage subsidence incidence were not statistically significant between the 2 groups. Conclusion: The ROI-C™ self-locking system is associated with shorter operation time, reduced blood loss, and lower incidences of postoperative adjacent segment degeneration and dysphagia compared to traditional CCP fixation. Both systems, however, demonstrated similar efficacy in neurological improvement and fusion rates. These results suggest that the ROI-C™ could be a preferable alternative in certain clinical scenarios to minimize specific postoperative complications.
- 19 September 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (38) , e44156
Open AccessEfficacy and safety of ROI-C™ self-locking system versus cage combined with screw-plate internal fixation in the treatment of degenerative cervical disease: A meta-analysis
Background: This meta-analysis rigorously compares the efficacy and safety of the ROI-C™ self-locking system with that of the traditional cage combined with screw-plate (CCP) internal fixation in treating degenerative cervical disease. The goal is to enhance surgical decision-making and improve patient outcomes in managing this condition. Methods: In this meta-analysis, we searched the PubMed, Embase, and Cochrane Library databases from their establishment to May 2024. We proposed to include randomized controlled trials (RCTs) and non-RCTs reported ROI-C™ self-locking system and CCP internal fixation for patients with degenerative cervical spondylosis, excluding published and unpublished literature on other study types, literature with incomplete or inadequate information, animal experiments, literature reviews, and systematic studies. Data were processed using STATA 15.1 software. Results: These studies encompassed both cohort studies and 1 RCT, involving a total of 918 patients (449 in the ROI-C group and 469 in the CCP group). Meta-analysis results showed that the ROI-C™ system is associated with shorter operation time and less blood loss compared to the CCP group. The incidences of postoperative adjacent segment degeneration and dysphagia were significantly lower in the ROI-C group. However, differences in Japanese Orthopedic Association scores, neck disability index scores, cervical lordosis, fusion rate, and cage subsidence incidence were not statistically significant between the 2 groups. Conclusion: The ROI-C™ self-locking system is associated with shorter operation time, reduced blood loss, and lower incidences of postoperative adjacent segment degeneration and dysphagia compared to traditional CCP fixation. Both systems, however, demonstrated similar efficacy in neurological improvement and fusion rates. These results suggest that the ROI-C™ could be a preferable alternative in certain clinical scenarios to minimize specific postoperative complications.
- Open Access
- 15 August 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (33) , e43767
The clinical outcomes of robotic-assisted total hip arthroplasty through the direct anterior approach: A meta-analysis and systematic review
Background: Existing evidence on the effectiveness of robotic-assisted total hip arthroplasty (THA) via the direct anterior approach compared to conventional THA is still scarce within evidence-based medicine. This meta-analysis seeks to bridge this gap by consolidating the available data. Methods: In this meta-analysis, we conducted searches across PubMed, Embase, Cochrane Library, CNKI, Wanfang, CQVIP, and CBM databases, covering records from their inception until January 2024. The included studies reported on the differences in clinical outcomes between robotic-assisted THA via the direct anterior approach and conventional THA. We excluded duplicate publications, studies lacking full text, incomplete data, animal experiments, literature reviews, and systematic studies from the analysis. All data were analyzed using STATA 15.1 statistical software. Results: This meta-analysis included 5 cohort studies with a total of 634 patients, with sample sizes ranging from 48 to 208. Of these, 290 patients were in the robotic-assisted group, while 344 were in the conventional group. The combined findings indicated a notable increase in acetabular inclination in robot-assisted THA when compared to that in conventional THA (standardized mean difference [SMD] = 0.75, 95% confidence interval [CI]: 0.02–1.47, P = .043). Moreover, robot-assisted THA demonstrated a significantly lower acetabular anteversion compared to that in the conventional THA (SMD = –0.34, 95% CI: –0.67 to –0.02, P = .039). Robot-assisted THA displayed a significantly diminished limb-length discrepancy in contrast to that in conventional THA (SMD = –0.24, 95% CI: –0.44 to –0.05, P = .015). Conclusion: In comparison to conventional THA, robotic-assisted THA through the direct anterior approach results in increased acetabular inclination, reduced acetabular anteversion, and improved limb-length consistency. The Harris Hip Score, however, did not significantly differ between the 2 approaches.
- 15 August 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (33) , e43767
Open AccessThe clinical outcomes of robotic-assisted total hip arthroplasty through the direct anterior approach: A meta-analysis and systematic review
Background: Existing evidence on the effectiveness of robotic-assisted total hip arthroplasty (THA) via the direct anterior approach compared to conventional THA is still scarce within evidence-based medicine. This meta-analysis seeks to bridge this gap by consolidating the available data. Methods: In this meta-analysis, we conducted searches across PubMed, Embase, Cochrane Library, CNKI, Wanfang, CQVIP, and CBM databases, covering records from their inception until January 2024. The included studies reported on the differences in clinical outcomes between robotic-assisted THA via the direct anterior approach and conventional THA. We excluded duplicate publications, studies lacking full text, incomplete data, animal experiments, literature reviews, and systematic studies from the analysis. All data were analyzed using STATA 15.1 statistical software. Results: This meta-analysis included 5 cohort studies with a total of 634 patients, with sample sizes ranging from 48 to 208. Of these, 290 patients were in the robotic-assisted group, while 344 were in the conventional group. The combined findings indicated a notable increase in acetabular inclination in robot-assisted THA when compared to that in conventional THA (standardized mean difference [SMD] = 0.75, 95% confidence interval [CI]: 0.02–1.47, P = .043). Moreover, robot-assisted THA demonstrated a significantly lower acetabular anteversion compared to that in the conventional THA (SMD = –0.34, 95% CI: –0.67 to –0.02, P = .039). Robot-assisted THA displayed a significantly diminished limb-length discrepancy in contrast to that in conventional THA (SMD = –0.24, 95% CI: –0.44 to –0.05, P = .015). Conclusion: In comparison to conventional THA, robotic-assisted THA through the direct anterior approach results in increased acetabular inclination, reduced acetabular anteversion, and improved limb-length consistency. The Harris Hip Score, however, did not significantly differ between the 2 approaches.
- Open Access
- 23 May 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (21) , e42631
The causal relationship between emotions and osteoarthritis: A bidirectional Mendelian randomization study
Previous study has observed the clinical relationship between affective disorders such as depression and anxiety and osteoarthritis (OA), however the gene causal effect was still unclear. The objective of this study was to evaluate the genetic causal effect of emotions on OA using bidirectional Mendelian randomization (MR), which is a novel methodology elucidating the causal relationship between diseases and screening for the potential driver genes. A bidirectional MR study was conducted to assess the causal effect of emotion on OA. The instrumental variables were selected from publicly available Genome-Wide Association Study summary datasets based on a P-value threshold (P < 5e−8) and linkage disequilibrium clumping criteria (r² < 0.001, window size = 10,000 kb). The robustness of the findings across different MR methods was validated by Cochran Q test, MR-Egger intercept test, MR_PRESSO, F-statistic, and statistical power. The inverse-variance weighted method was employed as the primary analysis due to its weighting approach, which minimizes variance and yields the most precise estimation of causal effects. While MR-Egger (assessed and accounted Pleiotropy), Weighted Median (adjusted for the potential confounding pleiotropy of instrumental variables), Weighted and Simple Mode (identified the effect clusters) methods were used as supplementary analyses to complement the outcome. The main genetic data source consisted of 10,083 participants obtained from publicly accessible repository. The emotions of depression, anxiousness, and hurt were found to have a genetic influence on the development of OA. Specifically, anxiousness was associated with a reduced risk of OA (odds ratio [OR] = 0.486, 95% confidence interval [CI] = 0.260–0.908, P = .024). On the other hand, depression (OR = 2.157, 95% CI = 1.605–2.899, P = 3.4e−07) and hurt (OR = 1.731, 95% CI = 1.092–2.745, P = .020) were identified as genetic factors that increased the susceptibility to OA. The statistical power of depression, anxious and feeling hurt on OA were > 0.99, 0.29, and > 0.99. These findings suggest that genetic factors underlying emotions, particularly depression and emotional distress, significantly influence susceptibility to OA, underscoring the potential for targeted mental health interventions in OA management.
- 23 May 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (21) , e42631
Open AccessThe causal relationship between emotions and osteoarthritis: A bidirectional Mendelian randomization study
Previous study has observed the clinical relationship between affective disorders such as depression and anxiety and osteoarthritis (OA), however the gene causal effect was still unclear. The objective of this study was to evaluate the genetic causal effect of emotions on OA using bidirectional Mendelian randomization (MR), which is a novel methodology elucidating the causal relationship between diseases and screening for the potential driver genes. A bidirectional MR study was conducted to assess the causal effect of emotion on OA. The instrumental variables were selected from publicly available Genome-Wide Association Study summary datasets based on a P-value threshold (P < 5e−8) and linkage disequilibrium clumping criteria (r² < 0.001, window size = 10,000 kb). The robustness of the findings across different MR methods was validated by Cochran Q test, MR-Egger intercept test, MR_PRESSO, F-statistic, and statistical power. The inverse-variance weighted method was employed as the primary analysis due to its weighting approach, which minimizes variance and yields the most precise estimation of causal effects. While MR-Egger (assessed and accounted Pleiotropy), Weighted Median (adjusted for the potential confounding pleiotropy of instrumental variables), Weighted and Simple Mode (identified the effect clusters) methods were used as supplementary analyses to complement the outcome. The main genetic data source consisted of 10,083 participants obtained from publicly accessible repository. The emotions of depression, anxiousness, and hurt were found to have a genetic influence on the development of OA. Specifically, anxiousness was associated with a reduced risk of OA (odds ratio [OR] = 0.486, 95% confidence interval [CI] = 0.260–0.908, P = .024). On the other hand, depression (OR = 2.157, 95% CI = 1.605–2.899, P = 3.4e−07) and hurt (OR = 1.731, 95% CI = 1.092–2.745, P = .020) were identified as genetic factors that increased the susceptibility to OA. The statistical power of depression, anxious and feeling hurt on OA were > 0.99, 0.29, and > 0.99. These findings suggest that genetic factors underlying emotions, particularly depression and emotional distress, significantly influence susceptibility to OA, underscoring the potential for targeted mental health interventions in OA management.
- Open Access
- 1 January 2025
- Published by Wiley in Mediators of Inflammation
- Vol. 2025 (1)
Neutrophils in Intracerebral Hemorrhage: Roles, Mechanisms, and Therapeutic Implications
Nontraumatic intracerebral hemorrhage (ICH), characterized by bleeding into the brain parenchyma, is a major cause of adult disability and mortality. The pathophysiology of ICH involves complex processes, including mass effect and subsequent inflammatory responses, which cause severe primary and secondary brain damage. As the first responders in neuroinflammatory reactions, neutrophils are rapidly recruited to the hemorrhage site. They interact with other immune cells, release cytotoxic molecules, and significantly exacerbate neuroinflammation. In the acute phase, neutrophils secrete cytokines, chemokines and neutrophil extracellular traps (NETs), which are particularly detrimental to brain tissue. However, in later stages, infiltrated neutrophils can adopt an immunosuppressive phenotype, exerting beneficial effects. Emerging evidence reveals that neutrophils play a multifaceted role in ICH progression, shifting between anti‐inflammatory or pro‐inflammatory phenotypes depending on brain tissue niche. Hence, tuning neutrophils into a beneficial phenotype represents a promising therapeutic strategy for ICH. We conducted a comprehensive literature search in PubMed and Web of Science databases for relevant studies published up to July 2025, using keywords including “intracerebral hemorrhage (ICH),” “neutrophil,” “inflammation,” “neuroinflammation,” “ neutrophil extracellular traps (NETs),” “treatment,” “therapy,“ and “therapeutics.” In this article, we explore the roles of neutrophils in ICH, encompassing their recruitment, activation mechanisms, interactions with other immune cells, and impact on neuroinflammation and neuronal injury. Furthermore, we discuss therapeutic strategies targeting neutrophil‐mediated pathways in ICH, highlighting potential avenues for future research and clinical intervention.
- 1 January 2025
- Published by Wiley in Mediators of Inflammation
- Vol. 2025 (1)
Open AccessNeutrophils in Intracerebral Hemorrhage: Roles, Mechanisms, and Therapeutic Implications
Nontraumatic intracerebral hemorrhage (ICH), characterized by bleeding into the brain parenchyma, is a major cause of adult disability and mortality. The pathophysiology of ICH involves complex processes, including mass effect and subsequent inflammatory responses, which cause severe primary and secondary brain damage. As the first responders in neuroinflammatory reactions, neutrophils are rapidly recruited to the hemorrhage site. They interact with other immune cells, release cytotoxic molecules, and significantly exacerbate neuroinflammation. In the acute phase, neutrophils secrete cytokines, chemokines and neutrophil extracellular traps (NETs), which are particularly detrimental to brain tissue. However, in later stages, infiltrated neutrophils can adopt an immunosuppressive phenotype, exerting beneficial effects. Emerging evidence reveals that neutrophils play a multifaceted role in ICH progression, shifting between anti‐inflammatory or pro‐inflammatory phenotypes depending on brain tissue niche. Hence, tuning neutrophils into a beneficial phenotype represents a promising therapeutic strategy for ICH. We conducted a comprehensive literature search in PubMed and Web of Science databases for relevant studies published up to July 2025, using keywords including “intracerebral hemorrhage (ICH),” “neutrophil,” “inflammation,” “neuroinflammation,” “ neutrophil extracellular traps (NETs),” “treatment,” “therapy,“ and “therapeutics.” In this article, we explore the roles of neutrophils in ICH, encompassing their recruitment, activation mechanisms, interactions with other immune cells, and impact on neuroinflammation and neuronal injury. Furthermore, we discuss therapeutic strategies targeting neutrophil‐mediated pathways in ICH, highlighting potential avenues for future research and clinical intervention.
- Open Access
- 22 November 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (47) , e40343
Transcription factors in tanshinones: Emerging mechanisms of transcriptional regulation
Transcription factors play a crucial role in the biosynthesis of tanshinones, which are significant secondary metabolites derived from Salvia miltiorrhiza, commonly known as Danshen. These compounds have extensive pharmacological properties, including anti-inflammatory and cardioprotective effects. This review delves into the roles of various transcription factor families, such as APETALA2/ethylene response factor, basic helix-loop-helix, myeloblastosis, basic leucine zipper, and WRKY domain-binding protein, in regulating the biosynthetic pathways of tanshinones. We discuss the emerging mechanisms by which these transcription factors influence the synthesis of tanshinones, both positively and negatively, by directly regulating gene expression or forming complex regulatory networks. Additionally, the review highlights the potential applications of these insights in enhancing tanshinone production through genetic and metabolic engineering, setting the stage for future advancements in medicinal plant research.
- 22 November 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (47) , e40343
Open AccessTranscription factors in tanshinones: Emerging mechanisms of transcriptional regulation
Transcription factors play a crucial role in the biosynthesis of tanshinones, which are significant secondary metabolites derived from Salvia miltiorrhiza, commonly known as Danshen. These compounds have extensive pharmacological properties, including anti-inflammatory and cardioprotective effects. This review delves into the roles of various transcription factor families, such as APETALA2/ethylene response factor, basic helix-loop-helix, myeloblastosis, basic leucine zipper, and WRKY domain-binding protein, in regulating the biosynthetic pathways of tanshinones. We discuss the emerging mechanisms by which these transcription factors influence the synthesis of tanshinones, both positively and negatively, by directly regulating gene expression or forming complex regulatory networks. Additionally, the review highlights the potential applications of these insights in enhancing tanshinone production through genetic and metabolic engineering, setting the stage for future advancements in medicinal plant research.
- Open Access
- 19 September 2024
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 23 (12) , 4223-4229
Exploring Genetic Drug Targets in Acne Vulgaris: A Comprehensive Proteome‐Wide Mendelian Randomization Study
Background: Acne vulgaris presents a substantial clinical challenge due to its complex pathophysiology and significant impact on quality of life. Identification of novel therapeutic targets for acne using genetic tools can guide the development of more effective treatments. Methods: Utilizing a dataset comprising 35 559 Icelandic individuals, we performed proteomic analyses to quantify 4709 circulating proteins. We integrated these data with acne‐specific genome‐wide association studies (GWAS) encompassing 34 422 acne patients and 364 991 controls. Mendelian randomization (MR) analyses employed the TwoSampleMR tool and Summary‐data‐based Mendelian Randomization (SMR) to estimate the causal effects of identified proteins on acne risk. Colocalization analyses assessed the likelihood of shared genetic etiology between protein levels and acne using the “coloc” R package. Results: Our proteome‐wide MR analysis initially identified 128 proteins potentially associated with acne risk. Following multiple testing corrections using the Benjamini–Hochberg method, fatty acid synthase (FASN) and tissue inhibitor of metalloproteinases 4 (TIMP4) remained significantly associated with acne risk. FASN exhibited a protective effect against acne (OR = 0.768, 95% CI: 0.676–0.872, p = 4.685E‐05), while TIMP4 was associated with an increased risk (OR = 1.169, 95% CI: 1.103–1.241, p = 1.956E‐07). Colocalization analysis supported a shared genetic basis for these protein‐acne associations, with posterior probabilities indicating strong evidence of shared causal variants. Conclusion: Our findings highlight the utility of integrative genomic approaches in identifying potential therapeutic targets for acne. FASN and TIMP4, in particular, demonstrate strong potential as targets for therapeutic intervention, pending further validation through clinical research. These results offer a foundation for targeted acne treatment development, aligning with personalized medicine principles.
- 19 September 2024
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 23 (12) , 4223-4229
Open AccessExploring Genetic Drug Targets in Acne Vulgaris: A Comprehensive Proteome‐Wide Mendelian Randomization Study
Background: Acne vulgaris presents a substantial clinical challenge due to its complex pathophysiology and significant impact on quality of life. Identification of novel therapeutic targets for acne using genetic tools can guide the development of more effective treatments. Methods: Utilizing a dataset comprising 35 559 Icelandic individuals, we performed proteomic analyses to quantify 4709 circulating proteins. We integrated these data with acne‐specific genome‐wide association studies (GWAS) encompassing 34 422 acne patients and 364 991 controls. Mendelian randomization (MR) analyses employed the TwoSampleMR tool and Summary‐data‐based Mendelian Randomization (SMR) to estimate the causal effects of identified proteins on acne risk. Colocalization analyses assessed the likelihood of shared genetic etiology between protein levels and acne using the “coloc” R package. Results: Our proteome‐wide MR analysis initially identified 128 proteins potentially associated with acne risk. Following multiple testing corrections using the Benjamini–Hochberg method, fatty acid synthase (FASN) and tissue inhibitor of metalloproteinases 4 (TIMP4) remained significantly associated with acne risk. FASN exhibited a protective effect against acne (OR = 0.768, 95% CI: 0.676–0.872, p = 4.685E‐05), while TIMP4 was associated with an increased risk (OR = 1.169, 95% CI: 1.103–1.241, p = 1.956E‐07). Colocalization analysis supported a shared genetic basis for these protein‐acne associations, with posterior probabilities indicating strong evidence of shared causal variants. Conclusion: Our findings highlight the utility of integrative genomic approaches in identifying potential therapeutic targets for acne. FASN and TIMP4, in particular, demonstrate strong potential as targets for therapeutic intervention, pending further validation through clinical research. These results offer a foundation for targeted acne treatment development, aligning with personalized medicine principles.
- Open Access
- 10 May 2024
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 23 (9) , 2768-2778
Efficacy and safety of CO 2 fractional laser versus Er: YAG fractional laser in the treatment of atrophic acne scar: A meta‐analysis and systematic review
Background: To date, a consensus on the relative efficacy and safety of CO 2 fractional laser versus erbium‐doped yttrium aluminum garnet (Er:YAG) fractional laser treatments for atrophic acne scars has not been reached. This meta‐analysis aims to systematically assess and compare their effectiveness and safety in clinical practice. Methods: For this meta‐analysis, we conducted comprehensive searches in Pubmed, Embase, and Cochrane databases, covering publications from their inception up to August 2023. Our focus was on studies comparing fractional CO 2 laser with Er:YAG fractional laser treatments for atrophic acne scars. We excluded duplicate publications, research lacking full‐text access, incomplete data, or cases where data extraction was not feasible. Additionally, animal experiments, reviews, and systematic reviews were not considered. Data analysis was performed using STATA 15.1. Results: Eight studies (seven randomized controlled trials (RCTs) and a retrospective study) were included in this meta‐analysis. The sample size ranged from 28 to 106 with a total of 418 patients, including 210 in the CO 2 fractional group and 208 in Er:YAG fractional group. The pooled results showed that the effective rate of CO 2 fractional laser in treating atrophic acne scar was significantly higher than that of Er:YAG fractional laser (OR = 1.81, 95% CI: 1.08–3.01) and the downtime of CO 2 fractional laser in treating atrophic acne scar was significantly shorter than that of Er:YAG fractional laser (Weighted Mean Difference (WMD) = −2.11, 95% CI: −3.11 to −1.10). In addition, VAS of CO 2 fractional laser in treating atrophic acne scar was significantly higher than that of Er:YAG fractional laser (WMD = 1.77, 95% CI: 1.32–2.21) and the duration of erythema of CO 2 fractional laser in treating atrophic acne scar was significantly longer than that of Er:YAG fractional laser (WMD = 1.85, 95% CI: 1.63–2.07). However, there was no significant difference in the duration of pain and incidence of PIHbetween CO 2 fractional laser and of Er:YAG fractional laser. Conclusion: When it comes to treating atrophic acne scars, CO 2 fractional laser demonstrates superior efficacy and leads to shorter downtime. However, it is important to note that CO 2 fractional laser treatments tend to result in higher pain intensity and may carry a higher risk of post‐treatment pigmentation compared to Er:YAG fractional laser procedures.
- 10 May 2024
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 23 (9) , 2768-2778
Open AccessEfficacy and safety of CO 2 fractional laser versus Er: YAG fractional laser in the treatment of atrophic acne scar: A meta‐analysis and systematic review
Background: To date, a consensus on the relative efficacy and safety of CO 2 fractional laser versus erbium‐doped yttrium aluminum garnet (Er:YAG) fractional laser treatments for atrophic acne scars has not been reached. This meta‐analysis aims to systematically assess and compare their effectiveness and safety in clinical practice. Methods: For this meta‐analysis, we conducted comprehensive searches in Pubmed, Embase, and Cochrane databases, covering publications from their inception up to August 2023. Our focus was on studies comparing fractional CO 2 laser with Er:YAG fractional laser treatments for atrophic acne scars. We excluded duplicate publications, research lacking full‐text access, incomplete data, or cases where data extraction was not feasible. Additionally, animal experiments, reviews, and systematic reviews were not considered. Data analysis was performed using STATA 15.1. Results: Eight studies (seven randomized controlled trials (RCTs) and a retrospective study) were included in this meta‐analysis. The sample size ranged from 28 to 106 with a total of 418 patients, including 210 in the CO 2 fractional group and 208 in Er:YAG fractional group. The pooled results showed that the effective rate of CO 2 fractional laser in treating atrophic acne scar was significantly higher than that of Er:YAG fractional laser (OR = 1.81, 95% CI: 1.08–3.01) and the downtime of CO 2 fractional laser in treating atrophic acne scar was significantly shorter than that of Er:YAG fractional laser (Weighted Mean Difference (WMD) = −2.11, 95% CI: −3.11 to −1.10). In addition, VAS of CO 2 fractional laser in treating atrophic acne scar was significantly higher than that of Er:YAG fractional laser (WMD = 1.77, 95% CI: 1.32–2.21) and the duration of erythema of CO 2 fractional laser in treating atrophic acne scar was significantly longer than that of Er:YAG fractional laser (WMD = 1.85, 95% CI: 1.63–2.07). However, there was no significant difference in the duration of pain and incidence of PIHbetween CO 2 fractional laser and of Er:YAG fractional laser. Conclusion: When it comes to treating atrophic acne scars, CO 2 fractional laser demonstrates superior efficacy and leads to shorter downtime. However, it is important to note that CO 2 fractional laser treatments tend to result in higher pain intensity and may carry a higher risk of post‐treatment pigmentation compared to Er:YAG fractional laser procedures.
- Open Access
- 23 February 2024
- Published by Wiley in Clinical Cardiology
- Vol. 47 (2) , e24238
The predictive value of laboratory parameters for no‐reflow phenomenon in patients with ST‐elevation myocardial infarction following primary percutaneous coronary intervention: A meta‐analysis
To date, the predictive role of laboratory indicators for the phenomenon of no flow is unclear. Hence, our objective was to conduct a meta‐analysis to investigate the association between laboratory parameters and the risk of the no‐reflow phenomenon in patients with ST‐elevation myocardial infarction (STEMI) following primary percutaneous coronary intervention (PCI). This, in turn, aims to offer valuable insights for early clinical prediction of no‐reflow. We searched Pubmed, Embase, and Cochrane Library from the establishment of the database to October 2023. We included case‐control or cohort study that patients with STEMI following primary PCI. We excluded repeated publication, research without full text, incomplete information or inability to conduct data extraction and animal experiments, reviews, and systematic reviews. STATA 15.1 was used to analyze the data. The pooled results indicated that elevated white blood cell (WBC) count (odds ratio [OR] = 1.061, 95% confidence interval [CI]: 1.013–1.112), neutrophil count (OR = 1.324, 95% CI: 1.128–1.553), platelet (PLT) (OR = 1.002, 95% CI: 1.000–1.005), blood glucose (OR = 1.005, 95% CI: 1.002–1.009), creatinine (OR = 1.290, 95% CI: 1.070–1.555), total cholesterol (TC) (OR = 1.022, 95% CI: 1.012–1.032), d‐dimer (OR = 1.002, 95% CI: 1.001–1.004), and fibrinogen (OR = 1.010, 95% CI: 1.005–1.015) were significantly associated with increased risk of no‐reflow. However, elevated hemoglobin was significantly associated with decreased risk of no‐reflow. In conclusion, our comprehensive analysis highlights the predictive potential of various parameters in assessing the risk of no‐reflow among STEMI patients undergoing PCI. Specifically, WBC count, neutrophil count, PLT, blood glucose, hemoglobin, creatinine, TC, d‐dimer, and fibrinogen emerged as significant predictors. This refined risk prediction may guide clinical decision‐making, allowing for more targeted and effective preventive measures to mitigate the occurrence of no‐reflow in this patient population.
- 23 February 2024
- Published by Wiley in Clinical Cardiology
- Vol. 47 (2) , e24238
Open AccessThe predictive value of laboratory parameters for no‐reflow phenomenon in patients with ST‐elevation myocardial infarction following primary percutaneous coronary intervention: A meta‐analysis
To date, the predictive role of laboratory indicators for the phenomenon of no flow is unclear. Hence, our objective was to conduct a meta‐analysis to investigate the association between laboratory parameters and the risk of the no‐reflow phenomenon in patients with ST‐elevation myocardial infarction (STEMI) following primary percutaneous coronary intervention (PCI). This, in turn, aims to offer valuable insights for early clinical prediction of no‐reflow. We searched Pubmed, Embase, and Cochrane Library from the establishment of the database to October 2023. We included case‐control or cohort study that patients with STEMI following primary PCI. We excluded repeated publication, research without full text, incomplete information or inability to conduct data extraction and animal experiments, reviews, and systematic reviews. STATA 15.1 was used to analyze the data. The pooled results indicated that elevated white blood cell (WBC) count (odds ratio [OR] = 1.061, 95% confidence interval [CI]: 1.013–1.112), neutrophil count (OR = 1.324, 95% CI: 1.128–1.553), platelet (PLT) (OR = 1.002, 95% CI: 1.000–1.005), blood glucose (OR = 1.005, 95% CI: 1.002–1.009), creatinine (OR = 1.290, 95% CI: 1.070–1.555), total cholesterol (TC) (OR = 1.022, 95% CI: 1.012–1.032), d‐dimer (OR = 1.002, 95% CI: 1.001–1.004), and fibrinogen (OR = 1.010, 95% CI: 1.005–1.015) were significantly associated with increased risk of no‐reflow. However, elevated hemoglobin was significantly associated with decreased risk of no‐reflow. In conclusion, our comprehensive analysis highlights the predictive potential of various parameters in assessing the risk of no‐reflow among STEMI patients undergoing PCI. Specifically, WBC count, neutrophil count, PLT, blood glucose, hemoglobin, creatinine, TC, d‐dimer, and fibrinogen emerged as significant predictors. This refined risk prediction may guide clinical decision‐making, allowing for more targeted and effective preventive measures to mitigate the occurrence of no‐reflow in this patient population.
- Open Access
- 16 February 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (7) , e35832
Effect of fire needle combined with traditional Chinese medicine on psoriasis: A systematic review and meta-analysis
Background: The mechanism of action of fire acupuncture and Chinese medicine in psoriasis is unclear. In this paper, the efficacy of the 2 therapies was compared through a comprehensive analysis of their recurrence rates for clinical reference. Methods: In this meta-analysis, we searched PubMed, Embase, Cochrane Library, CNKI, Wanfang, CQVIP, and CBM data from the establishment of the databases to May 2023. The study proposed to use randomized controlled trial research methods, excluding published literature, unpublished literature, literature with incomplete or inadequate information, animal experiments, literature reviews and systematic studies. Data were processed using STATA 15.1 software. Results: Our group previous study found that the clinical efficacy of the fire-acupuncture group was significantly improved compared to that of Chinese herbal medicine alone (RR = 1.20, 95% CI: 1.13–1.27). Also, there were significant reductions in Psoriasis Area and Severity Index (PASI) score (SMD = −1.04,95% CI: −1.48 to −0.60), area of skin damage (SMD = −0.40,95% CI: −0.75 to −0.04), and pruritus (SMD = −1.04,95% CI: −1.32 to −0.76). Our previous study found that Dermatology Life Quality Index (DLQI) was significantly lower in the fire acupuncture group compared to herbal medicine alone (SMD = −1.61,95% CI: −3.08 to −0.15). The combined analysis found that the recurrence rate was significantly lower in the fire-acupuncture group compared to herbal medicine alone (RR = 0.21,95% CI:0.07–0.60). Conclusion: Fire needle can improve the efficacy of TCM in the treatment of psoriasis, including the area, severity and itching of skin lesions, and reduce the recurrence rate, which is worthy of clinical promotion.
- 16 February 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (7) , e35832
Open AccessEffect of fire needle combined with traditional Chinese medicine on psoriasis: A systematic review and meta-analysis
Background: The mechanism of action of fire acupuncture and Chinese medicine in psoriasis is unclear. In this paper, the efficacy of the 2 therapies was compared through a comprehensive analysis of their recurrence rates for clinical reference. Methods: In this meta-analysis, we searched PubMed, Embase, Cochrane Library, CNKI, Wanfang, CQVIP, and CBM data from the establishment of the databases to May 2023. The study proposed to use randomized controlled trial research methods, excluding published literature, unpublished literature, literature with incomplete or inadequate information, animal experiments, literature reviews and systematic studies. Data were processed using STATA 15.1 software. Results: Our group previous study found that the clinical efficacy of the fire-acupuncture group was significantly improved compared to that of Chinese herbal medicine alone (RR = 1.20, 95% CI: 1.13–1.27). Also, there were significant reductions in Psoriasis Area and Severity Index (PASI) score (SMD = −1.04,95% CI: −1.48 to −0.60), area of skin damage (SMD = −0.40,95% CI: −0.75 to −0.04), and pruritus (SMD = −1.04,95% CI: −1.32 to −0.76). Our previous study found that Dermatology Life Quality Index (DLQI) was significantly lower in the fire acupuncture group compared to herbal medicine alone (SMD = −1.61,95% CI: −3.08 to −0.15). The combined analysis found that the recurrence rate was significantly lower in the fire-acupuncture group compared to herbal medicine alone (RR = 0.21,95% CI:0.07–0.60). Conclusion: Fire needle can improve the efficacy of TCM in the treatment of psoriasis, including the area, severity and itching of skin lesions, and reduce the recurrence rate, which is worthy of clinical promotion.
- Open Access
- 2 February 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (5) , e37052
Efficacy of traditional Chinese medicine combined with Silibinin on nonalcoholic fatty liver disease: A meta-analysis and systematic review
Background: The efficacy and safety of traditional Chinese medicine (TCM) combined with Silibinin in the treatment of nonalcoholic fatty liver disease (NAFLD) are still inconclusive. This meta-analysis intends to evaluation to explore the clinical efficacy and quality assessment of traditional Chinese medicine in combination with Silymarin in the treatment of NAFLD, aiming to aims to provide evidence-based data analysis for researchers and clinical practitioners involved in TCM research for NAFLD, with the hope of facilitating wider adoption and application Methods: In this meta-analysis, we searched PubMed, Embase, Cochrane Library, CNKI, Wanfang, CQVIP and CBM databases from the establishment of the databases to Oct 2023. The study proposed to include studies that reported combination of TCM with Silibinin and Silibinin alone in the treatment of NAFLD, excluding studies for which full text was not available or for which data extraction was not possible; studies using animal studies; reviews and systematic reviews. All data were processed by STATA15.1 statistical software. Results: 16 randomized controlled trials (RCTs) were included in this meta-analysis. The sample size ranged from 48 to 120, with a total of 1335 patients, including 669 in the Combined treatment group and 384 in the Silibinin group. The findings indicated that the total effective rate of combined treatment group was significantly higher than that of Silibinin alone. Levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), total cholesterol (TC), triglycerides (TG), and gamma glutamyl transpeptidase (GGT) of combined treatment group were all significantly lower than that of western medicine alone. Additionally, after treating NAFLD with a combination of TCM and Silibinin, the TCM syndrome score were significantly lower than those observed with Silibinin alone. Conclusion: Traditional Chinese medicine in conjunction with Silibinin capsules has shown significant efficacy in the treatment of NAFLD, improving clinical symptoms, blood lipid levels, and liver function. Furthermore, it is essential to engage in multi-omics research, investigate iron death, and explore the gut microbiota as potential observational indicators for the diagnosis and inclusion criteria. Conducting more high-quality clinical experiments is necessary to further validate these findings.
- 2 February 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (5) , e37052
Open AccessEfficacy of traditional Chinese medicine combined with Silibinin on nonalcoholic fatty liver disease: A meta-analysis and systematic review
Background: The efficacy and safety of traditional Chinese medicine (TCM) combined with Silibinin in the treatment of nonalcoholic fatty liver disease (NAFLD) are still inconclusive. This meta-analysis intends to evaluation to explore the clinical efficacy and quality assessment of traditional Chinese medicine in combination with Silymarin in the treatment of NAFLD, aiming to aims to provide evidence-based data analysis for researchers and clinical practitioners involved in TCM research for NAFLD, with the hope of facilitating wider adoption and application Methods: In this meta-analysis, we searched PubMed, Embase, Cochrane Library, CNKI, Wanfang, CQVIP and CBM databases from the establishment of the databases to Oct 2023. The study proposed to include studies that reported combination of TCM with Silibinin and Silibinin alone in the treatment of NAFLD, excluding studies for which full text was not available or for which data extraction was not possible; studies using animal studies; reviews and systematic reviews. All data were processed by STATA15.1 statistical software. Results: 16 randomized controlled trials (RCTs) were included in this meta-analysis. The sample size ranged from 48 to 120, with a total of 1335 patients, including 669 in the Combined treatment group and 384 in the Silibinin group. The findings indicated that the total effective rate of combined treatment group was significantly higher than that of Silibinin alone. Levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), total cholesterol (TC), triglycerides (TG), and gamma glutamyl transpeptidase (GGT) of combined treatment group were all significantly lower than that of western medicine alone. Additionally, after treating NAFLD with a combination of TCM and Silibinin, the TCM syndrome score were significantly lower than those observed with Silibinin alone. Conclusion: Traditional Chinese medicine in conjunction with Silibinin capsules has shown significant efficacy in the treatment of NAFLD, improving clinical symptoms, blood lipid levels, and liver function. Furthermore, it is essential to engage in multi-omics research, investigate iron death, and explore the gut microbiota as potential observational indicators for the diagnosis and inclusion criteria. Conducting more high-quality clinical experiments is necessary to further validate these findings.